Home › Funds › Samsara BioCapital, LLC › SRRK

Samsara BioCapital, LLC position in SRRK

SCHOLAR ROCK HLDG CORP · Health Care

Samsara BioCapital, LLC reported holding 6,897,652 shares of SRRK (SCHOLAR ROCK HLDG CORP) in its Q2 2026 13F filing — a position valued at US$379.4M, representing 31.16% of its reported portfolio and ranking #1 among its reported holdings. Samsara BioCapital, LLC has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)6.90M sh
Reported value held$379.37M
Portfolio Weight31.16%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's SRRK position evolved

Samsara BioCapital, LLC first disclosed a stake in SRRK in Q3 2023 at 4,598,828 shares (US$32.7M). The position peaked in Q2 2026 at 6,897,652 shares, worth US$379.4M. Across 12 filings, Samsara BioCapital, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 6,897,652 shares valued at US$379.4M. Notable position changes include a 48% increase in Q4 2023 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.60M $32.65M New
Q4 2023 6.79M $127.63M Add
Q1 2024 6.79M $120.57M Hold
Q2 2024 6.79M $56.55M Hold
Q3 2024 6.79M $54.38M Hold
Q4 2024 5.61M $242.59M Reduce
Q1 2025 5.61M $180.45M Hold
Q2 2025 5.61M $198.81M Hold
Q3 2025 5.61M $209.02M Hold
Q4 2025 6.90M $303.84M Add
Q1 2026 6.90M $339.09M Hold
Q2 2026 6.90M $379.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRRK and 13F data

SRRK (SCHOLAR ROCK HLDG CORP) is a Health Care company. 53 other funds we track also report a position in SRRK — the largest reported positions include Siren, L.L.C. (US$526.6M), Orbis Allan Gray Ltd (US$326.3M), Redmile Group, LLC (US$237.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRRK

All SRRK fund holders →

FAQ

How long has Samsara BioCapital, LLC held SRRK?

Samsara BioCapital, LLC has disclosed SRRK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Samsara BioCapital, LLC's current position in SRRK?

As of Q2 2026, Samsara BioCapital, LLC holds 6.90M shares of SRRK (SCHOLAR ROCK HLDG CORP), valued at $379.37M, representing 31.16% of its reported portfolio and ranking #1.

Has Samsara BioCapital, LLC been buying or selling SRRK?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC held unchanged its position in SRRK. The position peaked in Q2 2026 at 6.90M shares.

Which other funds hold SRRK?

Other major institutional holders of SRRK include Siren, L.L.C., Orbis Allan Gray Ltd, Redmile Group, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.